This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Curcuma longa
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
Turmeric is a bright yellow spice derived from the rhizome of Curcuma longa, a member of the ginger family. It has been used for thousands of years in Ayurvedic and Traditional Chinese Medicine for its potent anti-inflammatory and antioxidant properties. Curcumin, its primary active compound, is one of the most extensively studied natural compounds in modern research.
Turmeric (Curcuma longa) is one of the most extensively studied medicinal herbs, with over 12,000 peer-reviewed publications. Its active compound curcumin demonstrates potent anti-inflammatory and antioxidant effects comparable to some NSAIDs in clinical trials, though bioavailability remains a significant challenge without formulation enhancements.
Curcumin modulates NF-κB, COX-2, and LOX inflammatory pathways while activating Nrf2 antioxidant response. It also influences epigenetic markers and gut microbiome composition. Bioavailability is enhanced 2,000% with piperine (black pepper extract) and further improved by liposomal or nanoparticle formulations.
Osteoarthritis pain reduction
Multiple RCTs show 500mg BCM-95 formulation comparable to ibuprofen
Anti-inflammatory effect
NF-κB inhibition demonstrated in vivo and in clinical trials
Metabolic syndrome improvement
Meta-analysis shows significant reduction in triglycerides and BMI
Depression symptom improvement
Small RCTs comparable to fluoxetine; larger trials needed
Cancer prevention
Promising preclinical data but insufficient human RCTs
Alzheimer's prevention
Epidemiological support from Indian populations; clinical trials ongoing
| Drug | Severity | Description |
|---|---|---|
| Warfarin (Coumadin) | Severe | Turmeric and curcumin may enhance anticoagulant effects of warfarin, increasing bleeding risk. |
| Sulfasalazine | Moderate | Turmeric may increase sulfasalazine blood levels, potentially increasing its therapeutic effects and side effects. |
| Tacrolimus | Moderate | Curcumin may increase tacrolimus blood levels, requiring monitoring in transplant patients. |
| Metformin | Mild | Turmeric may enhance the blood sugar-lowering effect of metformin, with potential benefit but requiring monitoring. |
| Clopidogrel (Plavix) | Moderate | Turmeric may increase the antiplatelet effect of clopidogrel, raising bleeding risk. |
Found an error or have a correction for Turmeric?
Report an Issue →